Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 151 to 200 of 2013

TitleReference numberPublishedLast updated
Avalglucosidase alfa for treating Pompe diseaseTA821
Avapritinib for treating advanced systemic mastocytosisTA1012
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)TA730
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Avelumab for treating metastatic Merkel cell carcinomaTA517
Avelumab for untreated metastatic Merkel cell carcinomaTA691
Avelumab with axitinib for untreated advanced renal cell carcinomaTA1120
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapiesTA872
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapyTA895
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphomaTA894
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatmentTA333
Axonics sacral neuromodulation system for treating refractory overactive bladderHTG554
Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemiaTA218
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blastsTA399
Babies, children and young people's experience of healthcareNG204
Balloon angioplasty of pulmonary vein stenosis in infantsHTG46
Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and childrenHTG45
Balloon catheter dilation of paranasal sinus ostia for chronic sinusitisHTG174
Balloon catheter insertion for Bartholin's cyst or abscessHTG204
Balloon cryoablation for Barrett's oesophagusHTG767
Balloon cryoablation for squamous dysplasia of the oesophagusHTG560
Balloon dilatation of pulmonary valve stenosisHTG40
Balloon dilatation of systemic to pulmonary arterial shunts in childrenHTG48
Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in childrenHTG47
Balloon dilation for chronic eustachian tube dysfunctionHTG534
Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labourHTG744
Balloon kyphoplasty for vertebral compression fracturesHTG108
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertensionHTG410
Balloon valvuloplasty for aortic valve stenosis in adults and childrenHTG49
Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal)TA732
Baricitinib for moderate to severe rheumatoid arthritisTA466
Baricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal)TA982
Baricitinib for treating moderate to severe atopic dermatitisTA681
Baricitinib for treating severe alopecia areataTA926
Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removalHTG503
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and managementNG231
Bed frames for adults in acute medical or surgical hospital wards: late-stage assessmentHTG759
Bedwetting in under 19sCG111
Behaviour change: digital and mobile health interventionsNG183
Behaviour change: general approachesPH6
Behaviour change: individual approachesPH49
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Belimumab for treating lupus nephritis (terminated appraisal)TA806
Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and overTA949
Belzutifan for treating tumours associated with von Hippel-Lindau diseaseTA1011
Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA694
Bendamustine for the first-line treatment of chronic lymphocytic leukaemiaTA216
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)TA206

Results per page

  1. 10
  2. 25
  3. 50
  4. All